Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy.
Aiello S, Gastoldi S, Bresin E, Galbusera M, Mele C, Daina E, Santarsiero D, Comai G, La Manna G, Martinatto C, Benigni A, Remuzzi G, Noris M. Aiello S, et al. Among authors: galbusera m. Kidney Int Rep. 2024 Aug 22;9(11):3318-3323. doi: 10.1016/j.ekir.2024.08.014. eCollection 2024 Nov. Kidney Int Rep. 2024. PMID: 39534196 Free PMC article. No abstract available.
The complement alternative pathway and hemostasis.
Noris M, Galbusera M. Noris M, et al. Among authors: galbusera m. Immunol Rev. 2023 Jan;313(1):139-161. doi: 10.1111/imr.13150. Epub 2022 Oct 22. Immunol Rev. 2023. PMID: 36271870 Review.
Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.
Ruggenenti P, Di Marco F, Cortinovis M, Lorini L, Sala S, Novelli L, Raimondi F, Gastoldi S, Galbusera M, Donadelli R, Mele C, Piras R, Noris M, Portalupi V, Cappelletti L, Carrara C, Tomatis F, Bernardi S, Perna A, Peracchi T, Diadei O, Benigni A, Remuzzi G. Ruggenenti P, et al. Among authors: galbusera m. PLoS One. 2021 Dec 20;16(12):e0261113. doi: 10.1371/journal.pone.0261113. eCollection 2021. PLoS One. 2021. PMID: 34928990 Free PMC article. Clinical Trial.
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant.
Piras R, Iatropoulos P, Bresin E, Todeschini M, Gastoldi S, Valoti E, Alberti M, Mele C, Galbusera M, Cuccarolo P, Benigni A, Remuzzi G, Noris M. Piras R, et al. Among authors: galbusera m. Front Med (Lausanne). 2020 Nov 3;7:579418. doi: 10.3389/fmed.2020.579418. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33224962 Free PMC article.
An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
Galbusera M, Noris M, Gastoldi S, Bresin E, Mele C, Breno M, Cuccarolo P, Alberti M, Valoti E, Piras R, Donadelli R, Vivarelli M, Murer L, Pecoraro C, Ferrari E, Perna A, Benigni A, Portalupi V, Remuzzi G. Galbusera M, et al. Am J Kidney Dis. 2019 Jul;74(1):56-72. doi: 10.1053/j.ajkd.2018.11.012. Epub 2019 Mar 7. Am J Kidney Dis. 2019. PMID: 30851964
57 results